Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas
about
Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular DiseasesMicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer TherapyUnraveling the Anticancer Effect of Curcumin and ResveratrolCathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell CarcinomaNobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells.Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.Tricetin suppresses the migration/invasion of human glioblastoma multiforme cells by inhibiting matrix metalloproteinase-2 through modulation of the expression and transcriptional activity of specificity protein 1.Anticancer Natural Compounds as Epigenetic Modulators of Gene ExpressionMelatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profilesMicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants.Circulating level of high mobility group box‑1 predicts the severity of community‑acquired pneumonia: Regulation of inflammatory responses via the c‑Jun N‑terminal signaling pathway in macrophages.Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.Melatonin as a potential inhibitory agent in head and neck cancer.Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression.Fisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression.Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells.Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses
P2860
Q26767400-46856075-914A-4055-8271-A00D897438ACQ26797487-8474FF2E-9F74-41E3-97EE-A150E4D72F89Q28073155-383284C9-6ED4-4208-B025-A833AF39D077Q28274479-F866FA71-8097-4BEC-B275-83D1D03B0FBFQ37376512-2FF5F75B-FCF6-4233-8CD3-6E63B546BF49Q37642555-C92399DA-6488-4755-B32D-E82797AB3341Q37708932-415EDFD0-CE0A-44AC-A5A8-DE3FC79FFCB0Q38702262-4EE4D09B-BFA3-45A5-84F5-311C4FAB4B25Q38717161-ACFB4766-56E2-477A-8FDD-5BD7A213308CQ38763316-632D5C63-29F7-49C3-935F-8A05C6D3A49BQ38769524-08D4EA6D-2C41-4BDC-B59A-22DA40DBEE2AQ38781428-14FE4628-B176-427B-8878-CD34C37B11A6Q38846122-3290623B-0530-4EE1-B62F-7C70F0D40DDEQ39214234-139E4407-2E20-45A7-AC19-0F5FE35C56E6Q40996633-223B135A-01A4-462C-B6F5-533CEDCD7B53Q41022877-EC9DFD02-3C5B-469B-8D32-B008C62FEB81Q41684014-FF3A829B-F28E-4220-918A-3E86269EF5A9Q42546594-C6A61A60-4B68-43EB-9E81-340EE9D046F3Q46374706-4EF0833E-375B-4842-86B9-D966682E4304Q47112398-5204AA1C-6BBC-4894-B1A7-48E98B4348CFQ47127766-7EA8CC64-58E8-43B0-900F-367E0BC05862Q47136272-36E2C0D2-0215-42B4-9825-444341281B4FQ47306639-63F2900F-B742-435D-9DF3-4C3D6971F341Q47745693-C3472B01-05E1-4FB3-8C38-E29F901543EBQ50545475-F83AD334-D3ED-4447-882A-7F65925837A6Q53446051-68894772-501D-4621-B167-8B212543E00BQ54224159-51A013C3-22CB-40A1-A7D3-F01CF8F840F7Q55209672-FB63E41D-57AB-4A35-B852-CB30E7B70C59Q58724085-681FC0F0-E2E0-4342-B0BF-B60B0CA8FB45
P2860
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@ast
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@en
type
label
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@ast
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@en
prefLabel
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@ast
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@en
P2093
P2860
P356
P1433
P1476
Upregulation of miR-328 and in ...... ability in human osteosarcomas
@en
P2093
Chih-Hsin Tang
Feng-Koo Hsieh
Ming-Hsien Chien
Shun-Fa Yang
Wei-Jiunn Lee
P2860
P304
P356
10.18632/ONCOTARGET.3088
P407
P577
2015-02-01T00:00:00Z